These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 38900057

  • 1. Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program.
    Ivsins A, Mansoor M, Bowles J, Bardwell G.
    J Stud Alcohol Drugs; 2024 Nov; 85(6):845-855. PubMed ID: 38900057
    [Abstract] [Full Text] [Related]

  • 2. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M, Foreman-Mackey A, Ivsins A, Bardwell G.
    Harm Reduct J; 2023 Apr 28; 20(1):61. PubMed ID: 37118799
    [Abstract] [Full Text] [Related]

  • 3. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
    Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J, Majalahti J, Toombs K, LeMaistre J, Selfridge M, Urbanoski K.
    Harm Reduct J; 2024 Jun 07; 21(1):111. PubMed ID: 38849866
    [Abstract] [Full Text] [Related]

  • 4. Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes.
    Bardwell G, Ivsins A, Mansoor M, Nolan S, Kerr T.
    CMAJ; 2023 May 15; 195(19):E668-E676. PubMed ID: 37188370
    [Abstract] [Full Text] [Related]

  • 5. Safer opioid supply: qualitative program evaluation.
    Haines M, O'Byrne P.
    Harm Reduct J; 2023 Apr 20; 20(1):53. PubMed ID: 37081500
    [Abstract] [Full Text] [Related]

  • 6. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.
    Int J Drug Policy; 2024 Sep 20; 131():104547. PubMed ID: 39159532
    [Abstract] [Full Text] [Related]

  • 7. Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs.
    Ivsins A, Bowles JM, Mansoor M, Kerr T, Bardwell G.
    Int J Drug Policy; 2024 Nov 20; 133():104601. PubMed ID: 39378778
    [Abstract] [Full Text] [Related]

  • 8. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts.
    Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G.
    J Subst Use Addict Treat; 2024 Feb 20; 157():209185. PubMed ID: 37865289
    [Abstract] [Full Text] [Related]

  • 9. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada.
    Schmidt RA, Kaminski N, Kryszajtys DT, Rudzinski K, Perri M, Guta A, Benoit AC, Bayoumi AM, Challacombe L, Hales J, Kenny K, Kolla G, O'Reilly E, Sereda A, Rai N, Strike C.
    Drug Alcohol Rev; 2023 Nov 20; 42(7):1825-1837. PubMed ID: 37718646
    [Abstract] [Full Text] [Related]

  • 10. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R.
    J Urban Health; 2021 Feb 20; 98(1):59-69. PubMed ID: 33118145
    [Abstract] [Full Text] [Related]

  • 11. "The machine doesn't judge": Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines.
    Bardwell G, Ivsins A, Wallace JR, Mansoor M, Kerr T.
    Soc Sci Med; 2024 Mar 20; 345():116683. PubMed ID: 38364722
    [Abstract] [Full Text] [Related]

  • 12. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G, Strike C.
    Int J Drug Policy; 2019 Dec 20; 74():127-135. PubMed ID: 31590088
    [Abstract] [Full Text] [Related]

  • 13. Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada.
    Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBeck K, Kerr T, Hayashi K.
    Int J Drug Policy; 2024 Oct 20; 132():104564. PubMed ID: 39236550
    [Abstract] [Full Text] [Related]

  • 14. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G.
    Subst Abuse Treat Prev Policy; 2022 Oct 08; 17(1):66. PubMed ID: 36209227
    [Abstract] [Full Text] [Related]

  • 15. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R.
    Drug Alcohol Depend; 2020 Nov 01; 216():108202. PubMed ID: 32948372
    [Abstract] [Full Text] [Related]

  • 16. Acceptability and anticipated effectiveness of a safe supply of opioids, among people who inject opioids in King County, WA.
    Palayew A, Banta-Green CJ, Lamont M, Damper D, Moreno C, Goodreau SM, Mooney SJ, Glick SN.
    Int J Drug Policy; 2024 May 01; 127():104389. PubMed ID: 38522176
    [Abstract] [Full Text] [Related]

  • 17. "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.
    Collins AB, Macon EC, Levin S, Wunsch C, Wightman RS.
    Int J Drug Policy; 2024 May 01; 127():104391. PubMed ID: 38490014
    [Abstract] [Full Text] [Related]

  • 18. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K, Yoon M, Graham B, Karamouzian M, Slaunwhite AK, Tsang V, Young S, Buxton JA.
    Harm Reduct J; 2020 Nov 23; 17(1):90. PubMed ID: 33228676
    [Abstract] [Full Text] [Related]

  • 19. Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada.
    Bardwell G, Ivsins A, Socías ME, Kerr T.
    J Subst Abuse Treat; 2021 Nov 23; 130():108418. PubMed ID: 34118706
    [Abstract] [Full Text] [Related]

  • 20. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R.
    Harm Reduct J; 2020 Mar 30; 17(1):23. PubMed ID: 32228646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.